The Prevalence and Patterns of Toxicity With Immune Checkpoint Inhibitors in Solid Tumors: A Real-World Experience From a Tertiary Care Center in Oman

Introduction Immune checkpoint inhibitors (ICIs) have revolutionized the management of multiple cancers over the last decade. They work by employing the immune system and exhibiting activity over T cells resulting in immune upregulation. Despite their widespread use, they produce side effects that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Salman, Bushra, AlWard, Nameer M, Al-Hashami, Zamzam, Al-Sharqi, Hadil, Al-Sayegh, Hasan, Burney, Ikram A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644178/
https://www.ncbi.nlm.nih.gov/pubmed/38021572
http://dx.doi.org/10.7759/cureus.47050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644178/
https://www.ncbi.nlm.nih.gov/pubmed/38021572
http://dx.doi.org/10.7759/cureus.47050

Ejemplares similares